Industry Trends
An Analysis of Worldwide Prescription and OTC Sales by Technology
(2002 - 2012)
By Mark P. Mathieu
EvaluatePharma® calculates that worldwide pharmaceutical sales from biotechnology products increased 20%, to $94bn, in 2007.
Read more
|
Latest eNewsletters
eCliniqua
New Privacy Concerns with 'HIPAA 2'
January 4, 2010
Pharma Services
News
Gentris Profile; PSN 2008 Highlights Report
January 13, 2010
|
 |
Sales Contacts
For advertising information contact: Alan El Faye
VP, Advertising Sales - Western US, Canada, Europe, Pacific Rim
213-300-3886
Kay O. Christopher
Regional Sales Manager, Advertising Sales - Eastern US, Midwest and India
860-693-2991
|
| |
Link to Us!
You are welcome to link to articles on our website. Contact Allison Proffitt for details.
e-Prints & Reprints
To post a full article from Weekly Update or Bio-IT World on your website (not just a link), or for paper reprints, please contact:
Ashley Zander
The YGS Group
717-505-9701 ext.125
|
|
|
| |
| IN THIS ISSUE |
 |
VisiGen Founder Sues Life Technologies for Fraud |
| |
Illumina Unveils New HiSeq2000 Sequencer |
| |
More to Your Future than Just Genes |
| |
News Briefs |
|
 |
| |
| |
| THIS WEEK IN BIO-IT |
| |
VisiGen Founder Sues Life Technologies for Fraud
By Kevin Davies
Susan Hardin, co-founder of next-generation sequencing company VisiGen Biotechnologies, has filed suit against Life Technologies, which acquired her company in 2008, for fraud and breach of contract. The suit seeks actual and exemplary damages in excess of $300 million. Read more.
|
|
| |
|
|
| |
Bio-IT Briefs
January 14 | Full Stories
- Pathway Genomics launches DNA Conversation Starters
- Sage and Pfizer announce partnership
- Nominations are open for the Dr. Paul Janssen Award for Biomedical Research
|
|
| |
 |
| |
| |
| |
| ELSEWHERE IN THE PRESS |
| |
Illumina Unveils New HiSeq2000 Sequencer
Illumina says it will begin shipping next month a new sequencing instrument, the HiSeq2000, that will decode a human genome for just $10,000 in material costs, with BGI (the Beijing Genomics Institute, China) buying 128 of the new machines. Forbes
More to Your Future than Just Genes
Lars Bygren starting studying a remote Swedish town in the late 1980's. Bygren wondered if the town's feast or famine history would have a measurable effect on the generations that came after. What he found is central to epigenetics. Time
|
|
|
 |
|
| |
WEBINAR
Next-Generation Clinical Trial and Data Management Applications
Sponsored by Adobe
This webinar introduces i3Cube - a web-based, fully integrated, clinical trial and data management system built on Adobe's LiveCycle® Enterprise Suite. I3 cube provides end-to-end automation that delivers unprecedented visibility into information that sponsors need to accelerate the study process and complete trials efficiently. Viewers will learn more about:
- Creating faster and more efficient trial processes
- Reducing investigator burden
- Real-time sponsor transparency into study information
- Enterprise solutions based on Adobe LiveCycle® ES utilizing cross-platform clients of Reader, Flash and AIR
Download now.
To have your podcast featured here, contact Lynn Cloonan for more information.
|
|
| |
SPONSORED LINKS
To have your product or service featured here, contact Lynn Cloonan for more information. |
|
| |
Insight Pharma Reports
Multiplex Assays: Evolving Technologies, Applications, & Future Directions
Author: Ken Rubenstein, Ph.D.
Multiplex Assays has generated a great deal of excitement in the past 15 years. This report examines the role of multiplex and multi-analyte biomarker assays in translational medicine. Read more.
|
|
| |
FEATURED EVENTS
- Adopting R&D Informatics Systems
- Molecular Med Tri-Conference Short Courses
- Tufts Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation | Feb 8-12, 2010 | Boston
- Electronic Data in Clinical Trials, March 8-9, 2010, Philadelphia
- eCTD 2010 - One Day Forum, March 10, 2010, Philadelphia
- Summit for Clinical Ops Executives (SCOPE) - March 8-11, 2010 | Philadelphia
- Drug Development Latin America, March 10-11, 2010, Philadelphia
- Bio-IT World Conference & Expo • April 20-22, 2010, World Trade Center •Boston, MA
- Bio-IT World Web Symposia Series
- Barnett Educational Services
- Cambridge Healthtech Events
To have your event featured here, contact Lynn Cloonan for more information.
|
|
|
|
| |
BEST PRACTICES 2010
Deadline Extended
|
The deadline for the 2010 Bio-IT World Best Practices Awards Program has been extended to February 19, 2010.
Share your organization's best practices with your peers. The Best Practices program recognizes individuals and teams for their novel and innovative uses of technology, business strategies, and solutions that improve some facet of the R&D / drug development / clinical trial process. Direct entries are encouraged as well as nominations from users and vendors.
"We're excited about this award and very honored to be a recipient of Best Practices from Bio-IT World." -Vanderbilt University; ActiveHealth Management
Submission details and entry form are available here. Deadline extended to February 19, 2010.
View the 2009 Best Practices Awards compendium today.
2010 Best Practices Categories
- Basic Research & Biological Research
- Drug Discovery & Development
- Clinical Trials & Research
- Translational Medicine
- Personalized Medicine
- IT & Informatics
- Knowledge Management
- Health-IT
- Manufacturing & Bioprocessing
If you have questions, write to aproffitt@healthtech.com
|
| |
| EXCLUSIVE WEBCAST |
Life Science Webcasts from Bio-IT World and Cambridge Healthtech Media Group
New
Moore's Law and the Future of Genome Sequencing
Guest: Jonathan Rothberg, Ph.D., Founder/CEO Ion Torrent Systems; Founder Curagen, 454 Life Sciences, Rain Dance
Editorial inteview conducted by Kevin Davies, Ph.D., Editor-in-Chief of Bio-IT World with Jonathan Rothberg reflecting on the past decade of his accomplishments and a glimpse at his new project, Ion Torrent Systems. Interview conducted at CHI's Exploring Next Generation Sequencing conference in September 2009. Download Now
New
Oxford Nanopore's Third-Generation Sequencing Technology
Guest: John Milton, Ph.D., Vice President Research, Oxford Nanopore Technologies UK
Editorial interview conducted by Kevin Davies, Ph.D., Editor-in-Chief of Bio-IT World with John Milton that offers insights into Oxford Nanopore's potentially revolutionary new sequencing technology, which marries exonuclease cleavage of DNA and protein nanopores. Interview conducted at CHI's Exploring Next Generation Sequencing conference in September 2009. Download Now
|
| |
| Contact the Editor |
We invite your comments and feedback for this edition of Weekly Update.
Managing Editor
|
|
Follow
